CH5132799

Item number	Size	Delivery time	Price
TGM-T2619-1mg	1 mg	7 - 10 business days*	55.00€
TGM-T2619-2mg	2 mg	7 - 10 business days*	83.00€
TGM-T2619-5mg	5 mg	7 - 10 business days*	138.00€
TGM-T2619-10mg	10 mg	7 - 10 business days*	225.00€
TGM-T2619-25mg	25 mg	7 - 10 business days*	418.00€
TGM-T2619-50mg	50 mg	7 - 10 business days*	619.00€
TGM-T2619-100mg	100 mg	7 - 10 business days*	882.00€
TGM-T2619-500mg	500 mg	7 - 10 business days*	1,782.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: CH5132799 has been used in trials studying the treatment of Solid Tumors. Target:... more

Close menu

Product information "CH5132799"

Description: CH5132799 has been used in trials studying the treatment of Solid Tumors. Target: mTOR, PI3K. Smiles: CS(=O)(=O)N1CCc2c1nc(nc2-c1cnc(N)nc1)N1CCOCC1. References: Tanaka H, et al, Clin Cancer Res, 2011, 17(10), 3272-3281.

Supplier:	TargetMol
Supplier-Nr:	T2619

Properties

Application:	PI3K alpha / beta / delta / gamma inhibitor
MW:	377.42 D
Formula:	C15H19N7O3S

Database Information

CAS :	1007207-67-1\| Matching products
KEGG ID :	K00922 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "CH5132799"

Write a review